Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-01-05 @ 10:40 AM
Study NCT ID:
NCT03083704
Status:
COMPLETED
Last Update Posted:
2023-08-08
First Post:
2017-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
Sponsor:
Portola Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-07
First Submit QC Date:
None
Study First Post Date:
2017-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-07
Last Update Post Date:
2023-08-08
Last Update Post Date Type:
ACTUAL